The page is the record's research on the issuer — no analyst, no rating, no view.

Defence Therapeutics Inc (DTC) — research page

CA · ca-cm-kg/CSE/DTC · as of 2026-11-06

Identity and listing

Defence Therapeutics Inc is listed on the CSE under the ticker DTC. Its ISIN is CA24463V1013; its LEI is not on the record. Its security type is Corporate, its sector is Life Sciences, and its jurisdiction is not on the record. Its segment is not on the record. The issuer is listed and not halted.

fieldvaluesource · read date
nameDefence Therapeutics Incsource · 2026-11-06
exchangeCSEsource · 2026-11-06
tickerDTCsource · 2026-11-06
ISINCA24463V1013source · 2026-11-06
LEInot on the record
security typeCorporatesource · 2026-11-06
segmentnot on the record
sectorLife Sciencessource · 2026-11-06
jurisdictionnot on the record
statuslisted, not haltedsource · 2026-11-08

The disclosure read

The record holds 22 filings in the twelve months to 2026-11-06, all of them newswire releases, on 18 filing days. The median gap between filing days is 16 days. The latest filing is dated 2026-10-23, 14 days before the record date. The CSE median cadence is 19.5 days across 724 issuers, and the Life Sciences sector median is 17.5 days across 200 issuers. The CSE median latency is 17.0 days and the Life Sciences sector median latency is 14 days. The CSE median filings count is 6.0 and the sector median is 7.0.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer221614
exchange median: CSE (724 issuers)619.517
sector median: Life Sciences (200 issuers)717.514
datetypecategoryfiling
2026-10-23newswire_releaseDefence Therapeutics Announces Convertible Debenture Interest Payment
2026-10-19newswire_releaseDefence Therapeutics Wins Best Poster Award and Takes Center Stage at World ADC San Diego 2026, a Key Recognition in the Field Highlighting the Potential of Its Accum Platform
2026-09-08newswire_releaseDefence Therapeutics CEO Highlights Recent Progress and Outlines Strategic Priorities in Letter to Shareholders
2026-09-04newswire_releaseDefence Therapeutics Provides Updates on Sharing Agreement
2026-08-04newswire_releaseDefence Therapeutics Appoints Dr. Amie Phinney as President and Chief Executive Officer

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is Crowe MacKay LLP; its location is not on the record. The record holds no auditor changes.

Events and halts

The record holds no listing, delisting, name change, domicile change or segment move lines. The halt flag is clear: listed, not halted.

Orderability

Under the rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1, chapter as of 2026-11-04, the outcome for Paragraph (o) of the definition is signal ACM-200 and is determinable. The outcome for Paragraph (q) of the definition is signal ACM-200 and is determinable.

client categoryoutcome
Paragraph (o) of the definitionACM-200
Paragraph (q) of the definitionACM-200

rule acm-68000/ca/kyp-know-your-product-ni-31-103/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The field has not been read, so no research houses are recorded on the issuer's investor-relations page.

Open research

The field has not been read, so no openly published research notes are recorded.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The market's vintage is not sealed. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed. The live record began on 2026-09-10.

Sources

7 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://thecse.com/api/webapi/listed-companies/ (identity.exchange)
10.2
https://www.investing.com/equities/defence-therapeutics (identity.isin)
10.3
https://mcp.ca-cm-kg.ai/events/CSE/DTC (the disclosure lines)
10.4
https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)
10.5
https://thecse.com/listings/defence-therapeutics-inc/ (the auditor)
10.6
https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)
10.7
https://mcp.ca-cm-kg.ai/record/CSE/DTC (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"CA24463V1013"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:1f482e916c784a48.